Sudarshan Pharma Industries Ltd
NSE: BSE: 543828
₹34.19
(4.97%)
Mon, 25 May 2026, 05:16 pm
Market Cap7.84B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSudarshan Pharma Industries Financials
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total revenue | 1.48B | 1.93B | 3.57B | 4.61B | 4.64B | 5.05B |
| Gross profit | 82.67M | 119.33M | 139.17M | 192.76M | 283.14M | 492.97M |
| Operating expenses (excl. COGS) | -32.04M | -55.11M | -37.66M | -50.56M | -65.47M | -109.67M |
| Selling/general/admin expenses, total | -32.04M | -55.11M | -37.66M | -50.56M | -59.87M | -105.55M |
| Research & development | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -32.04M | -55.11M | -37.66M | -50.56M | -59.87M | -105.55M |
| Other operating expenses, total | 0 | 0 | 0 | 0 | -5.61M | -4.12M |
| Operating income | 50.63M | 64.22M | 101.51M | 142.20M | 217.67M | 383.30M |
| Non-operating income, total | -33.47M | -28.48M | -30.15M | -47.23M | -65.38M | -167.01M |
| Interest expense, net of interest capitalized | -27.23M | -32.25M | -33.79M | -54.02M | -89.44M | -157.72M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | -673.00K | 3.78M | 3.64M | 6.79M | 24.06M | 18.89M |
| Non-operating interest income | 109.00K | 253.00K | 1.99M | 4.90M | 7.88M | 5.55M |
| Miscellaneous non-operating expense | -782.00K | 3.52M | 1.65M | 1.89M | 16.18M | 13.34M |
| Unusual income/expense | -5.57M | 0 | 0 | 0 | 0 | -28.17M |
| Pretax income | 17.16M | 35.75M | 71.36M | 94.96M | 152.28M | 216.29M |
| Taxes | -4.41M | -9.03M | -18.87M | -24.59M | -37.73M | -56.76M |
| Non-controlling/minority interest | 0 | 0 | -7.00K | 0 | 0 | 23.00K |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 12.75M | 26.71M | 52.48M | 70.37M | 114.55M | 159.55M |
| Net income | 12.75M | 26.71M | 52.48M | 70.37M | 114.55M | 159.55M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 12.75M | 26.71M | 52.48M | 70.37M | 114.55M | 159.55M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - |
| EBITDA | 54.10M | 71.64M | 110.17M | 151.27M | 230.11M | 405.51M |
| EBIT | 50.63M | 64.22M | 101.51M | 142.20M | 217.67M | 383.30M |
| Total operating expenses | -1.43B | -1.87B | -3.47B | -4.47B | -4.42B | -4.67B |
| Prepaid expenses | — | 1.21M | 1.82M | 4.76M | 17.84M | 20.31M |
| Deferred income, current | — | — | 4.32M | 13.47M | 25.48M | 4.08M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — |
| Deferred tax liabilities | 794.00K | 1.37M | 1.41M | 2.10M | 711.00K | 4.67M |
| Deferred income, non-current | — | — | — | — | — | — |
| Minority interest | 0 | 483.00K | 0 | 0 | 0 | 7.00K |
| Change in accrued expenses | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | -7.22M | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |